|Bid||469.10 x 800|
|Ask||471.40 x 1100|
|Day's Range||466.42 - 472.97|
|52 Week Range||393.88 - 612.27|
|Beta (5Y Monthly)||0.70|
|PE Ratio (TTM)||37.00|
|Earnings Date||Sept 22, 2022|
|Forward Dividend & Yield||3.60 (0.78%)|
|Ex-Dividend Date||Apr 28, 2022|
|1y Target Est||553.33|
Storch Advisors CEO, and former CEO of Toys R Us and Hudson’s Bay, Gerald Storch sits down with Yahoo Finance Live to break down Bed Bath & Beyond's unraveling after a Q1 earnings miss and the dismissal of its CEO, its pandemic-era business, and the outlook of the retail industry.
Yahoo Finance’s Jared Blikre breaks down how markets opened on Monday.
Inflation is running amok in the U.S., and that's likely prompting a few fully justified questions about what to do with your portfolio. Between justified fears of inflation contributing to a prolonged bear market and the economic pressure that inflation inherently forces onto investors via rising prices, it's not shocking that people are thinking about selling stocks. Take CVS Health (NYSE: CVS), for example.